4d Pharma PLC 14 June 2022 Pre AGM-Investor Presentation and Q&A Leeds, UK, 14 June 2022 , - 4D pharma plc (AIM: DDDD, Nasdaq LBPS), a...
4d Pharma PLC 07 June 2022 Exercise of Options and Total Voting Rights Leeds, UK, 7 June 2022 , - 4D pharma plc (AIM: DDDD, Nasdaq LBPS), a...
eeds, England-based pharmaceutical company - Plans to conduct a phase II study to assess the safety of MRx0518 in comb ...
4d Pharma PLC 27 May 2022 4D pharma Presents Trial in Progress Poster on the Phase II Study of MRx0518 in Combination with BAVENCIO(R) in Patients...
- Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months - Study sites are open for patient...
4d Pharma PLC 25 May 2022 4D pharma plc (the "Company" or "4D") Annual Report and Notice of AGM Leeds, UK, May 25, 2022 - 4D...
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class...
4d Pharma PLC 17 May 2022 4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the...
eeds, England-based pharmaceutical company - Says part A of the phase I/II trial of MRx-4DP0004 for the treatment of a ...
...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads